 Victoria Pelak
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 10 | 2024 | 452 | 3.220 |
Why?
| | Vision Disorders | 13 | 2023 | 130 | 2.790 |
Why?
| | Neurodegenerative Diseases | 4 | 2022 | 95 | 2.040 |
Why?
| | Eye Movements | 3 | 2021 | 52 | 1.330 |
Why?
| | Atrophy | 6 | 2024 | 153 | 1.320 |
Why?
| | Cerebral Cortex | 6 | 2022 | 391 | 1.230 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2024 | 10 | 0.940 |
Why?
| | Eye Diseases | 2 | 2020 | 76 | 0.920 |
Why?
| | Lewy Body Disease | 2 | 2020 | 16 | 0.870 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 282 | 0.870 |
Why?
| | Dementia | 3 | 2023 | 185 | 0.820 |
Why?
| | Tremor | 2 | 2021 | 45 | 0.810 |
Why?
| | Nervous System Diseases | 2 | 2020 | 254 | 0.790 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 9 | 0.780 |
Why?
| | Ocular Motility Disorders | 4 | 2018 | 25 | 0.780 |
Why?
| | Visual Perception | 2 | 2022 | 139 | 0.770 |
Why?
| | Fragile X Syndrome | 1 | 2021 | 74 | 0.760 |
Why?
| | Macular Degeneration | 1 | 2022 | 151 | 0.720 |
Why?
| | Reading | 1 | 2021 | 152 | 0.710 |
Why?
| | Mucolipidoses | 1 | 2019 | 7 | 0.690 |
Why?
| | Tomography, Optical Coherence | 4 | 2022 | 127 | 0.690 |
Why?
| | Visual Pathways | 3 | 2018 | 43 | 0.670 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 343 | 0.630 |
Why?
| | Coronavirus Infections | 2 | 2020 | 336 | 0.630 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.620 |
Why?
| | Migraine Disorders | 1 | 2018 | 79 | 0.590 |
Why?
| | Neurology | 1 | 2018 | 85 | 0.590 |
Why?
| | Visual Fields | 5 | 2022 | 76 | 0.590 |
Why?
| | Ophthalmology | 1 | 2018 | 77 | 0.580 |
Why?
| | Androgens | 1 | 2016 | 165 | 0.500 |
Why?
| | Aging | 3 | 2023 | 1636 | 0.490 |
Why?
| | Magnetic Resonance Imaging | 10 | 2024 | 3070 | 0.480 |
Why?
| | Visual Acuity | 7 | 2023 | 273 | 0.480 |
Why?
| | Optic Neuropathy, Ischemic | 3 | 2012 | 30 | 0.460 |
Why?
| | Testosterone | 1 | 2016 | 333 | 0.440 |
Why?
| | Pandemics | 2 | 2020 | 1330 | 0.440 |
Why?
| | Humans | 48 | 2024 | 115297 | 0.430 |
Why?
| | Cognition | 2 | 2023 | 980 | 0.370 |
Why?
| | Inflammation | 1 | 2020 | 2482 | 0.350 |
Why?
| | Optic Nerve Diseases | 2 | 2009 | 31 | 0.350 |
Why?
| | Optic Neuritis | 3 | 2020 | 37 | 0.350 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 2 | 2020 | 43 | 0.340 |
Why?
| | Vision, Low | 1 | 2009 | 14 | 0.340 |
Why?
| | Optic Nerve | 1 | 2009 | 65 | 0.330 |
Why?
| | Giant Cell Arteritis | 3 | 2020 | 48 | 0.300 |
Why?
| | Brain Diseases | 2 | 2017 | 127 | 0.300 |
Why?
| | Congresses as Topic | 2 | 2019 | 201 | 0.290 |
Why?
| | Male | 24 | 2024 | 55796 | 0.260 |
Why?
| | Cataract Extraction | 1 | 2006 | 76 | 0.260 |
Why?
| | Aged | 12 | 2023 | 19253 | 0.250 |
Why?
| | Nerve Net | 2 | 2022 | 226 | 0.250 |
Why?
| | Pseudotumor Cerebri | 2 | 2016 | 22 | 0.240 |
Why?
| | Cognition Disorders | 2 | 2023 | 474 | 0.240 |
Why?
| | Middle Aged | 18 | 2024 | 26936 | 0.230 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 97 | 0.220 |
Why?
| | Cognitive Aging | 1 | 2023 | 13 | 0.220 |
Why?
| | Immunosuppressive Agents | 4 | 2020 | 663 | 0.210 |
Why?
| | Lewy Bodies | 1 | 2022 | 3 | 0.210 |
Why?
| | Female | 23 | 2024 | 59773 | 0.210 |
Why?
| | Neuropsychological Tests | 3 | 2022 | 924 | 0.210 |
Why?
| | Unconsciousness | 1 | 2022 | 18 | 0.210 |
Why?
| | Phacoemulsification | 1 | 2023 | 107 | 0.200 |
Why?
| | Ataxia | 1 | 2021 | 36 | 0.200 |
Why?
| | White Matter | 1 | 2023 | 105 | 0.200 |
Why?
| | Amnesia | 2 | 2012 | 42 | 0.200 |
Why?
| | Diffusion Tensor Imaging | 2 | 2023 | 67 | 0.200 |
Why?
| | Retinal Ganglion Cells | 1 | 2022 | 92 | 0.200 |
Why?
| | Retrospective Studies | 8 | 2024 | 12588 | 0.190 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2021 | 61 | 0.190 |
Why?
| | Trochlear Nerve Diseases | 1 | 2001 | 6 | 0.190 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2001 | 9 | 0.190 |
Why?
| | Abducens Nerve Diseases | 1 | 2001 | 10 | 0.190 |
Why?
| | Cataract | 1 | 2023 | 184 | 0.190 |
Why?
| | Stents | 2 | 2016 | 471 | 0.180 |
Why?
| | Myasthenia Gravis | 1 | 2020 | 18 | 0.180 |
Why?
| | Brain | 6 | 2023 | 2371 | 0.180 |
Why?
| | Siderosis | 1 | 1999 | 2 | 0.180 |
Why?
| | Autonomic Fibers, Preganglionic | 1 | 1999 | 4 | 0.180 |
Why?
| | Pupil | 1 | 1999 | 13 | 0.180 |
Why?
| | Eye Movement Measurements | 1 | 2019 | 10 | 0.170 |
Why?
| | Immunomodulation | 1 | 2020 | 89 | 0.170 |
Why?
| | West Nile Fever | 1 | 2020 | 50 | 0.170 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 139 | 0.170 |
Why?
| | Brain Stem | 1 | 2000 | 101 | 0.170 |
Why?
| | Hearing Loss | 1 | 2023 | 182 | 0.170 |
Why?
| | Steroids | 1 | 2020 | 146 | 0.170 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2019 | 36 | 0.170 |
Why?
| | Immune System | 1 | 2020 | 174 | 0.160 |
Why?
| | Facial Recognition | 1 | 2019 | 27 | 0.160 |
Why?
| | San Francisco | 1 | 2018 | 56 | 0.160 |
Why?
| | Postoperative Complications | 2 | 2023 | 2160 | 0.160 |
Why?
| | Frontotemporal Dementia | 1 | 2019 | 34 | 0.160 |
Why?
| | Facial Expression | 1 | 2019 | 59 | 0.160 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2018 | 42 | 0.150 |
Why?
| | Vestibule, Labyrinth | 1 | 2018 | 54 | 0.150 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 20 | 0.150 |
Why?
| | Critical Care | 1 | 2021 | 478 | 0.140 |
Why?
| | Transverse Sinuses | 1 | 2016 | 8 | 0.140 |
Why?
| | Adult | 13 | 2022 | 30576 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2021 | 3035 | 0.140 |
Why?
| | Papilledema | 2 | 2018 | 38 | 0.140 |
Why?
| | Immunotherapy | 1 | 2020 | 489 | 0.140 |
Why?
| | Universities | 1 | 2018 | 338 | 0.140 |
Why?
| | Laser Therapy | 1 | 2017 | 99 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 172 | 0.130 |
Why?
| | Brain Mapping | 3 | 2022 | 516 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 944 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2018 | 328 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 3450 | 0.110 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2023 | 85 | 0.110 |
Why?
| | Biomedical Research | 1 | 2019 | 594 | 0.110 |
Why?
| | Multiple Sclerosis | 3 | 2020 | 381 | 0.110 |
Why?
| | Hippocampus | 1 | 2017 | 708 | 0.110 |
Why?
| | Autoantibodies | 2 | 2018 | 1322 | 0.110 |
Why?
| | Optic Disk Drusen | 1 | 2012 | 5 | 0.100 |
Why?
| | Hemodynamics | 1 | 2016 | 962 | 0.100 |
Why?
| | Visual Field Tests | 1 | 2011 | 13 | 0.100 |
Why?
| | Cranial Sinuses | 1 | 2011 | 12 | 0.100 |
Why?
| | Optic Disk | 2 | 2009 | 36 | 0.100 |
Why?
| | Hemianopsia | 1 | 2011 | 9 | 0.100 |
Why?
| | Memory, Episodic | 1 | 2012 | 38 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2384 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1344 | 0.090 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 157 | 0.090 |
Why?
| | Nervous System Malformations | 1 | 2009 | 33 | 0.080 |
Why?
| | Hypokinesia | 1 | 2008 | 7 | 0.080 |
Why?
| | Stiff-Person Syndrome | 1 | 2008 | 7 | 0.080 |
Why?
| | Age of Onset | 2 | 2020 | 451 | 0.080 |
Why?
| | Rest | 2 | 2022 | 102 | 0.070 |
Why?
| | Arteritis | 1 | 2006 | 27 | 0.070 |
Why?
| | Spinal Nerve Roots | 1 | 2005 | 30 | 0.060 |
Why?
| | Cranial Nerve Diseases | 1 | 2005 | 41 | 0.060 |
Why?
| | Animals | 4 | 2023 | 32091 | 0.060 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2005 | 120 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1805 | 0.060 |
Why?
| | Blindness, Cortical | 1 | 2003 | 5 | 0.060 |
Why?
| | Adolescent | 6 | 2020 | 17767 | 0.060 |
Why?
| | Gliosis | 1 | 2023 | 31 | 0.060 |
Why?
| | Neurites | 1 | 2023 | 44 | 0.060 |
Why?
| | Demography | 1 | 2024 | 264 | 0.050 |
Why?
| | Young Adult | 4 | 2022 | 10413 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4436 | 0.050 |
Why?
| | Pulvinar | 1 | 2022 | 4 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2024 | 194 | 0.050 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 164 | 0.050 |
Why?
| | Diplopia | 1 | 2001 | 16 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 251 | 0.050 |
Why?
| | Connectome | 1 | 2022 | 63 | 0.050 |
Why?
| | Functional Laterality | 1 | 2022 | 200 | 0.050 |
Why?
| | Strabismus | 1 | 2001 | 26 | 0.050 |
Why?
| | Treatment Failure | 2 | 2016 | 331 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 4960 | 0.050 |
Why?
| | Vision Tests | 1 | 2000 | 15 | 0.050 |
Why?
| | Vision, Ocular | 1 | 2000 | 29 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2020 | 79 | 0.050 |
Why?
| | Temporal Lobe | 2 | 2012 | 83 | 0.040 |
Why?
| | Demyelinating Diseases | 1 | 2020 | 76 | 0.040 |
Why?
| | New Orleans | 1 | 2019 | 13 | 0.040 |
Why?
| | Eye Pain | 1 | 2018 | 7 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2018 | 49 | 0.040 |
Why?
| | Encephalitis | 1 | 2020 | 127 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2023 | 9127 | 0.040 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 255 | 0.040 |
Why?
| | Recurrence | 1 | 2020 | 946 | 0.040 |
Why?
| | Focus Groups | 1 | 2018 | 389 | 0.030 |
Why?
| | Transfection | 1 | 2018 | 858 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 610 | 0.030 |
Why?
| | Child, Preschool | 2 | 2020 | 9124 | 0.030 |
Why?
| | Hospital Mortality | 1 | 1999 | 780 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1045 | 0.030 |
Why?
| | Patient Participation | 1 | 2018 | 367 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2018 | 779 | 0.030 |
Why?
| | Emotions | 1 | 2019 | 477 | 0.030 |
Why?
| | Child | 3 | 2020 | 18435 | 0.030 |
Why?
| | Qualitative Research | 1 | 2018 | 969 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4033 | 0.030 |
Why?
| | Disease Management | 1 | 2016 | 558 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2023 | 6432 | 0.030 |
Why?
| | Color Vision Defects | 1 | 2012 | 6 | 0.030 |
Why?
| | Spinal Puncture | 1 | 2012 | 15 | 0.030 |
Why?
| | Phlebography | 1 | 2011 | 40 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2011 | 111 | 0.020 |
Why?
| | Lymphokines | 1 | 1991 | 114 | 0.020 |
Why?
| | Stroke | 1 | 1999 | 1015 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4635 | 0.020 |
Why?
| | Hospitalization | 1 | 1999 | 1745 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2854 | 0.020 |
Why?
| | Autoradiography | 1 | 1989 | 71 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1218 | 0.020 |
Why?
| | Supranuclear Palsy, Progressive | 1 | 2008 | 6 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 1991 | 383 | 0.020 |
Why?
| | Macaca mulatta | 1 | 1989 | 129 | 0.020 |
Why?
| | Saccades | 1 | 2008 | 35 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1989 | 116 | 0.020 |
Why?
| | Blindness | 1 | 2008 | 37 | 0.020 |
Why?
| | Oculomotor Muscles | 1 | 2008 | 40 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 1991 | 374 | 0.020 |
Why?
| | Withholding Treatment | 1 | 2008 | 68 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2008 | 156 | 0.020 |
Why?
| | Frontal Lobe | 1 | 1989 | 138 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2008 | 123 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2008 | 152 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1355 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2008 | 150 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1051 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1715 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1991 | 629 | 0.020 |
Why?
| | Electromyography | 1 | 2008 | 323 | 0.020 |
Why?
| | Cranial Nerves | 1 | 2005 | 11 | 0.020 |
Why?
| | Sural Nerve | 1 | 2005 | 19 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2005 | 40 | 0.020 |
Why?
| | Graves Disease | 1 | 2005 | 32 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 454 | 0.020 |
Why?
| | Hypertrophy | 1 | 2005 | 113 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2811 | 0.010 |
Why?
| | Mice | 1 | 2020 | 15075 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 146 | 0.010 |
Why?
| | Axons | 1 | 2005 | 180 | 0.010 |
Why?
| | Disease Progression | 1 | 2008 | 2423 | 0.010 |
Why?
| | Contrast Sensitivity | 1 | 2000 | 12 | 0.010 |
Why?
| | Observer Variation | 1 | 2000 | 298 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2008 | 1455 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 739 | 0.010 |
Why?
| | Walking | 1 | 2000 | 425 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2401 | 0.010 |
Why?
| | Age Factors | 1 | 1999 | 2908 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 5540 | 0.010 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 84 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1991 | 189 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1991 | 79 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1991 | 66 | 0.010 |
Why?
| | CD3 Complex | 1 | 1991 | 92 | 0.010 |
Why?
| | Receptors, Fc | 1 | 1991 | 45 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 97 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 310 | 0.010 |
Why?
| | Base Sequence | 1 | 1991 | 2104 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2773 | 0.000 |
Why?
| | Gene Expression | 1 | 1991 | 1451 | 0.000 |
Why?
| | RNA | 1 | 1991 | 816 | 0.000 |
Why?
|
|
Pelak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|